|
Hi, Our Q1 masterclass explored what it means for biopharma communicators to show up fully as strategic partners, focusing on how we understand the business, structure our work, and make our impact more visible. Andrea Johnston led the session, bringing a builder’s perspective shaped by 30+ years across corporate, agency, and entrepreneurship (including one of the OG firms in our industry, Pure Communications). Here are 10 takeaways that stood out:
And, if you missed the session (or want a second pass), the replay and Andrea’s slides are available here. I particularly found the discourse around project- vs. value-based pricing (#7 above) intriguing and on-point as our profession evolves. Together, these points paint a clearer picture of where the role is heading, and where expectations are already shifting within our industry. A big thank you to Andrea for sharing so-many well-earned insights! We already have the Q2 masterclass cooking – stay tuned! Lynnea |
Hi! Burnout is often discussed as an issue for individuals to manage. But during our April Comm Convo, Beyond Self-Care to Structural Change, the discussion focused on the systems, expectations, and leadership habits that shape how sustainable our jobs are. Our speakers Arran Attridge (Attridge Communications), Nikki Little (Franco), Amanda Guisbond (Iambic), and Barbara Palmer (Broad Perspectives Consulting) discussed how burnout develops inside comms teams, why urgency drives our...
Hi! A quick reminder that T2B’s inaugural AI in Biopharma Communications Survey closes tonight. Take the survey We’re exploring how communicators are using AI in practice, what tools and governance structures are in place, where friction remains, and how the role itself may be changing. The goal is to create a benchmark our profession can actually use in conversations about policy, training, resourcing, and the future of the function. Thank you to everyone who has already taken the time to...
Hi and happy Friday! First, I want to flag that this is not one of those surveys where you can watch from afar and see what everyone else says. Yes, we have about 1,600(!) members in the T2B community, but we are calling on each of you to set aside 10 minutes to share your individual experience, hopes, fears, challenges, and expectations around AI in our profession. If we want this inaugural AI in Biopharma Communications Survey to be meaningful and instructive, we need as much data as...